Research Pipeline

AlterRNA's innovative RNA therapeutics and biotech research projects

20

Total Projects

Filters

  • mRNA Therapeutics
  • Gene Editing
  • Immunotherapy
  • Oncology

  • mRNA Therapeutics
  • Gene Editing
  • Immunotherapy
  • Oncology

Showing 9 projects

ARN-7845 mRNA Cancer Vaccine

Novel mRNA-based therapeutic vaccine designed to stimulate immune response against patient-specific tumor mutations in melanoma and

Oncology Phase 2

Research Focus

Personalized neoantigen-targeting mRNA vaccine for solid tumors

arrow

80% Funded

$2,000,000 of $2,500,000
I'm Interested

RNA-Editing Platform for DMD

Innovative RNA-editing approach to restore dystrophin expression through targeted correction of genetic mutations.

Gene Editing Preclinical

Research Focus

CRISPR-based RNA editing for Duchenne Muscular Dystrophy

arrow

45% Funded

$1,000,000 of $2,000,000
I'm Interested

Immunomodulatory mRNA-LNP

Development of next-generation lipid nanoparticle formulations for targeted delivery of immunomodulatory mRNA therapeutics.

Immunotherapy Discovery

Research Focus

Lipid nanoparticle delivery for autoimmune diseases

arrow

45% Funded

$2,000,800 of $3,000,000
I'm Interested

CAR-T Enhancement via mRNA

Enhancing chimeric antigen receptor T-cell therapy through transient mRNA transfection for improved efficacy and safety.

Immunotherapy Phase I

Research Focus

mRNA-mediated enhancement of CAR-T cell therapy

arrow

50% Funded

$1,000,000 of $3,000,000
I'm Interested

ALT-9124 Rare Disease Program

Protein replacement strategy using mRNA technology for treating lysosomal storage disorders.

mRNA Immunotherapy Phase I

Research Focus

mRNA replacement therapy for enzyme deficiency disorders

arrow

80% Funded

$4,000,000 of $5,000,000
I'm Interested